TELA Bio, Inc. Shareholders' Equity
TELA Bio, Inc. (TELA) had Shareholders' Equity of -$15.87 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-11
- 2026-06-30: Stockholders' Equity Attributable to Parent -$15.87M.
- 2026-03-31: Stockholders' Equity Attributable to Parent -$5.20M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $6.31M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $1.56M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | -$15.87M 10-Q · filed 2026-08-11 |
| 2026-03-31 | -$5.20M 10-Q · filed 2026-08-11 |
| 2025-12-31 | $6.31M 10-Q · filed 2026-08-11 |
| 2025-09-30 | $1.56M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $9.18M 10-Q · filed 2026-08-11 |
| 2025-03-31 | $18.12M 10-Q · filed 2026-08-11 |
| 2024-12-31 | $28.46M 10-Q · filed 2026-08-11 |
| 2024-09-30 | -$6.27M 10-Q · filed 2025-11-14 |
| 2024-06-30 | $2.87M 10-Q · filed 2025-11-14 |
| 2024-03-31 | $14.38M 10-Q · filed 2025-08-11 |
| 2023-12-31 | $18.88M 10-K · filed 2026-03-25 |
| 2023-09-30 | $30.55M 10-Q · filed 2024-11-08 |
| 2023-06-30 | $40.01M 10-Q · filed 2024-11-08 |
| 2023-03-31 | $3.14M 10-Q · filed 2024-08-13 |
| 2022-12-31 | $14.30M 10-K · filed 2026-03-25 |
| 2022-09-30 | $23.30M 10-Q · filed 2023-11-13 |
| 2022-06-30 | -$1.54M 10-Q · filed 2023-11-13 |
| 2022-03-31 | $10.04M 10-Q · filed 2023-08-10 |
| 2021-12-31 | $20.10M 10-K · filed 2025-03-21 |
| 2021-09-30 | $27.73M 10-Q · filed 2022-11-10 |
| 2021-06-30 | $34.97M 10-Q · filed 2022-11-10 |
| 2021-03-31 | $41.69M 10-Q · filed 2022-08-11 |
| 2020-12-31 | $49.03M 10-K · filed 2024-03-22 |
| 2020-09-30 | $56.33M 10-Q · filed 2021-11-12 |
| 2020-06-30 | $63.40M 10-Q · filed 2021-11-12 |
| 2020-03-31 | $24.23M 10-Q · filed 2021-08-12 |
| 2019-12-31 | $30.96M 10-K · filed 2023-03-23 |
| 2019-09-30 | -$160.40M 10-Q · filed 2020-11-12 |
| 2019-06-30 | -$153.75M 10-Q · filed 2020-11-12 |
| 2019-03-31 | -$145.79M 10-Q · filed 2020-08-13 |
| 2018-12-31 | -$137.86M 10-K · filed 2022-03-23 |
| 2018-09-30 | -$128.54M 10-Q · filed 2019-12-18 |
| 2018-06-30 | -$123.93M 10-Q · filed 2019-12-18 |
| 2017-12-31 | -$108.17M 10-K · filed 2021-03-25 |
| 2016-12-31 | -$81.17M 10-K · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| InspireMD, Inc. (NSPR) | $0.033B |